Quantitative structure–activity relationship

Quantitative structure–activity relationship
Name	Quantitative structure–activity relationship
Field	Computational chemistry, Chemoinformatics, Medicinal chemistry
Foundation	Corwin Hansch, Toshio Fujita
Related	Quantitative structure–property relationship, Molecular docking, Pharmacophore

Quantitative structure–activity relationship. A Quantitative structure–activity relationship (QSAR) is a computational modeling method used to correlate the chemical structure of molecules with their biological activity or physicochemical properties. These mathematical models are foundational in drug discovery and toxicology for predicting the behavior of untested compounds. The approach relies on the principle that structurally similar molecules exhibit similar activities, enabling the rational design of new chemical entities.

Overview

The core objective of a QSAR study is to derive a predictive equation linking molecular descriptors to a biological endpoint, such as IC50 or LD50. This process involves quantifying chemical structure through parameters like log P, molar refractivity, and various topological indices. Pioneering work by Corwin Hansch established the Hansch analysis, which uses linear regression to relate biological activity to hydrophobicity and electronic effects. These models are critically applied within regulatory frameworks like those of the European Chemicals Agency to assess chemical safety.

History and development

The conceptual origins of QSAR trace back to the 19th century with observations by Crum-Brown and Thomas Fraser on the relationship between physiological action and chemical composition. The modern era began in the 1960s with the seminal contributions of Corwin Hansch and Toshio Fujita, who developed the Hansch equation. Concurrently, Svante Wold advanced the field through multivariate analysis techniques. The establishment of the Comparative Molecular Field Analysis method by Richard Cramer in the 1980s represented a major shift towards three-dimensional QSAR. Landmark applications include the development of ACE inhibitors and work supported by the National Institutes of Health.

Methodology and approaches

QSAR methodologies are broadly categorized by the dimensionality of the molecular descriptors used. Traditional 2D-QSAR utilizes constitutional descriptors and substituent constants, often analyzed via multiple linear regression. More advanced 3D-QSAR techniques, such as Comparative Molecular Field Analysis and Comparative Molecular Similarity Indices Analysis, require molecular alignment and probe interaction fields. The advent of 4D-QSAR incorporates ensemble sampling, while 5D and 6D-QSAR account for ligand and receptor flexibility. Machine learning algorithms, including support vector machines and random forest methods, are now routinely applied for model construction and validation.

Applications

The primary application of QSAR is in drug discovery, where it guides lead optimization and virtual screening campaigns within pharmaceutical companies like Pfizer and GlaxoSmithKline. It is instrumental in predicting ADME properties and identifying potential CYP450 inhibitors. In environmental science, QSAR models are used for ecological risk assessment and to predict properties regulated under REACH. The Food and Drug Administration and the Organisation for Economic Co-operation and Development utilize QSAR for prioritizing chemicals for toxicological testing, aiding in the assessment of endocrine disruptors and mutagens.

Limitations and challenges

A significant limitation of QSAR is the requirement for high-quality, congeneric training data, as models often fail to extrapolate beyond their applicability domain. The curse of dimensionality can arise when using an excessive number of molecular descriptors relative to data points. Critics, including practitioners of systems biology, argue that traditional QSAR oversimplifies complex biological systems and protein-ligand interactions. Regulatory acceptance depends on rigorous validation per OECD principles, and models can be confounded by metabolite formation or prodrug activation not captured by parent compound structure.

Software and tools

A wide array of commercial and academic software packages facilitate QSAR modeling. Prominent commercial platforms include Schrödinger's suite, BIOVIA Discovery Studio, and OpenEye Scientific Software toolkits. The Tripos legacy software SYBYL was historically central for Comparative Molecular Field Analysis. Open-source tools are widely used, such as RDKit for descriptor calculation, KNIME for workflow automation, and Orange for data mining. The CDK and PaDEL-Descriptor libraries are also essential for cheminformatics research, often conducted at institutions like the University of North Carolina or the Novartis Institutes for BioMedical Research.

Category:Computational chemistry Category:Medicinal chemistry Category:Cheminformatics